Table 1.
Patient characteristics in all IBD patients and those with NAFLD at index and at 5-year follow-up
| Demographics | All IBD patients (n = 1672) | IBD patients with NAFLD (n = 207) | IBD patients with NAFLD and index NFS (n = 138) | IBD patients with NAFLD and 5-year follow-up (n = 56) |
|---|---|---|---|---|
| Sex, n (%) | ||||
| Male | 752 (45) | 96 (46) | 68 (49) | 25 (45) |
| Female | 920 (55) | 111 (54) | 70 (51) | 31 (55) |
| Mean age (y ± SD) | 48 ± 15.6 | 50.6 ± 13.6 | 49.6 ± 13.3 | 52.1 ± 12.4 |
| BMI (mean ± SD), n (%) | 25.9 ± 6.8 | 29.5 ± 8 | 29.7 ± 7.8 | 30.8 ± 8.3 |
| Underweight < 18.5 | 54 (3) | 12 (6) | 7 (5) | 2 (3) |
| Normal 18.5–24.9 | 420 (25) | 42 (20) | 33 (24) | 11 (20) |
| Overweight 25–29.9 | 245 (15) | 42 (20) | 32 (23) | 19 (34) |
| Obese > 30 | 213 (13) | 79 (38) | 66 (48) | 24 (43) |
| Blank | 740 (44) | 32 (16) | 0 (0) | 0 (0) |
| Race, n (%) | ||||
| Caucasian | 1325 (79) | 162 (78) | 105 (76) | 42 (75) |
| African-American | 260 (16) | 35 (17) | 26 (19) | 13 (23) |
| Asian | 51 (3) | 3 (2) | 2 (1) | 1 (2) |
| Other | 36 (2) | 7 (3) | 5 (4) | 0 (0) |
| IBD type, n (%) | ||||
| Crohn’s disease | 897 (55) | 131 (63) | 86 (62) | 39 (70) |
| Ulcerative colitis | 453 (27) | 39 (19) | 24 (17) | 10 (18) |
| Undetermined type | 67 (4) | 9 (4) | 5 (4) | 0 (0) |
| Microscopic | 30 (1) | 3 (1) | 0 (0) | 0 (0) |
| Eosinophilic | 1 (0) | 0 (0) | 0 (0) | 0 (0) |
| Unclassified | 224 (13) | 26 (13) | 23 (17) | 7 (12) |
| Medication history, n (%) | ||||
| 5-ASA use | 334 (20) | 36 (17) | 23 (17) | 10 (18) |
| Immunosuppressant use | 790 (47) | 106 (51) | 65 (47) | 35 (63) |
| Biologic use | 745 (45) | 116 (56) | 75 (54) | 37 (66) |